4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-25-005645
Chief Financial Officer acquired 2,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
PISKEL KYLE · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-14 | Exercise or conversion : show line 1 in the form | +2,500 | $6.32 | $15,800 | 271,510 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-14 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −2,500 | 0 | D |
Loading xslF345X05/form4.xml…